These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 16577403

  • 1. Reversible Coagulation in Living Tissue: IX.
    Bancroft WD, Gutsell RS, Rutzler JE.
    Proc Natl Acad Sci U S A; 1931 Dec; 17(12):637-42. PubMed ID: 16577403
    [No Abstract] [Full Text] [Related]

  • 2. Living donor liver transplantation from an asymptomatic donor with mild coagulation factor IX deficiency: report of a case.
    Sanada Y, Sasanuma H, Sakuma Y, Morishima K, Kasahara N, Kaneda Y, Miki A, Fujiwara T, Shimizu A, Hyodo M, Hirata Y, Yamada N, Okada N, Ihara Y, Urahashi T, Madoiwa S, Mimuro J, Mizuta K, Yasuda Y.
    Pediatr Transplant; 2014 Dec; 18(8):E270-3. PubMed ID: 25213132
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Factor IX thrombogenicity: in vivo effects on coagulation activation and a case report of disseminated intravascular coagulation.
    Small M, Lowe GD, Douglas JT, Forbes CD, Prentice CR.
    Thromb Haemost; 1982 Aug 24; 48(1):76-7. PubMed ID: 7135346
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Extrinsic activation of human blood coagulation factors IX and X.
    Bom VJ, Reinalda-Poot JH, Cupers R, Bertina RM.
    Thromb Haemost; 1990 Apr 12; 63(2):224-30. PubMed ID: 2363125
    [Abstract] [Full Text] [Related]

  • 11. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
    Osterud B, Kasper CK, Lavine KK, Prodanos C, Rapaport SI.
    Thromb Haemost; 1981 Feb 23; 45(1):55-9. PubMed ID: 7245126
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Factor IX of the blood coagulation system: a review.
    Taran LD.
    Biochemistry (Mosc); 1997 Jul 23; 62(7):685-93. PubMed ID: 9331959
    [Abstract] [Full Text] [Related]

  • 14. [STUDIES ON FACTOR IX ACTIVITY. I. RELATION BETWEEN SERUM THROMBOPLASTIN GENERATION TEST AND WHOLE BLOOD CLOTTING TIME, WITH SPECIAL REFERENCE TO THE MODE OF ACTION OF FACTOR IX AND CONTACT FACTOR].
    MATSUOKA T.
    Nihon Ketsueki Gakkai Zasshi; 1963 Apr 23; 26():231-43. PubMed ID: 14043489
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Establishment of a hemophilia B transgenic mouse model on the basis of coagulation factor IX gene knock-out mouse].
    Che WL, He Y, Yao ZZ, Li J, Fu JL.
    Yi Chuan Xue Bao; 2002 Jul 23; 29(7):594-8. PubMed ID: 12143307
    [Abstract] [Full Text] [Related]

  • 19. Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX.
    McGraw RA, Davis LM, Noyes CM, Lundblad RL, Roberts HR, Graham JB, Stafford DW.
    Proc Natl Acad Sci U S A; 1985 May 23; 82(9):2847-51. PubMed ID: 3857619
    [Abstract] [Full Text] [Related]

  • 20. Functions of AAV-CMV-F.IX And AAV-EF1alpha-F.IX in gene therapy for hemophilia B.
    Wiwanitkit V.
    Hum Gene Ther; 2007 Feb 23; 18(2):89-92. PubMed ID: 17266422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.